Daily Stock Opinions and Ratings

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Opinions

Jim Cramer - Mad MoneyKaruna TherapeuticsKRTXCOMMENTDec 01, 2021

An early-stage biopharma, so you can't buy their drugs right now, but they are developing drugs. Their lead drug treats schizophrenia as well as psychosis. Shares are up 21% YTD, but has pulled back hard in the past month.

Jim Cramer - Mad Money

Unknown

$123.05

Stock price when the opinion was issued

$329.83

As of Mar 15, 2024. Market Open.

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY

They have been working on a drug for schizophrenia. Early this month they released phase 3 trail results--which were great. Shares jumped 72% and keep climbing.

Popular Articles

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

© 2000 - 2026 Stockchase Inc.